The clinical efficacy of a new slow release preparation of the calcium antagonist gallopamil was assessed in 20 patients by diary cards and treadmill exercise tests. A single blind phase of two week periods of placebo, gallopamil 100 mg o.d. and gallopamil 100 mg b.i.d., blinded to the patient, was
A Comparative Study of Once-Daily Amlodipine versus Twice-Daily Diltiazem Controlled Release (CR) in the Treatment of Stable Angina Pectoris
β Scribed by H.A.M. van Kesteren; A.J.A.M. Withagen
- Book ID
- 110253801
- Publisher
- Springer US
- Year
- 1998
- Tongue
- English
- Weight
- 90 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0920-3206
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The aim of this multicentre randomised double blind study was to compare the efficacy and safety of the 200-300 mg sustained release diltiazem formulation administered once daily (200-300 SR) with standard diltiazem (D) given three or four times daily to patients with stable angina. Patients aged 59
## Background: Calcipotriol and betamethasone dipropionate are both widely used, effective treatments for psoriasis. vitamin d analogues and topical corticosteroids have different mechanisms of action in the treatment of psoriasis. a new vehicle has been developed in order to contain both calcipotr